Hakan Küçükkepeci

Dr. Hakan Küçükkepeci

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2021 in Journal of Nervous & Mental Disease
Verified
Journal Article
Closed access
ABAysegul Bilen
Aysegul Bilen
HKHakan Küçükkepeci
Hakan Küçükkepeci
Limited data are available for real-world impact of the COVID-19 pandemic on chronic pain patients. This study aimed to evaluate pain intensity, depression, and anxiety status in chronic pain patients during the COVID-19 pandemic. A total of 110 patients with chronic pain participated on a voluntary basis in this questionnaire survey. The questionnaire form elicited information on sociodemographic characteristics and prepandemic and pandemic data on analgesic need, access to medication, visual analog scale (VAS) pain, Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) scores. The COVID-19 pandemic resulted in increased levels of depression (74.5%), anxiety (66.4%), increase in analgesic need (60%), and limited access to analgesic drugs (40.0%). In conclusion, our findings revealed significant increase in VAS pain intensity, BDI, and BAI scores during the COVID-19 pandemic compared with prepandemic period among chronic pain patients, particularly for patients with increased need of analgesics during pandemic.

1 December 2021 in European Archives of Medical Research
Verified
Journal Article
Closed access
ETEsra Akdaş Tekin
Esra Akdaş Tekin
AMAylin Meke
Aylin Meke
HKHakan Küçükkepeci
Hakan Küçükkepeci
SÖSuzan Deniz Önol
Suzan Deniz Önol
FŞFunda Şimsek
Funda Şimsek
NTNamigar Turgut
Namigar Turgut


Verified
Journal Article
Open access
PDF file
HKHakan Küçükkepeci
Hakan Küçükkepeci
SMSinan Mutlu
Sinan Mutlu
RKrasim onur Karaoglu
rasim onur Karaoglu
AKAçelya Toprak Karaoğlu
Açelya Toprak Karaoğlu
ÖSÖzge Sayın
Özge Sayın
NTNamigar Turgut
Namigar Turgut
Background: Vasoplegic shock (VS) in critically ill patients without microbiological evidence of infection poses a major clinical challenge in intensive care units (ICUs). Extracorporeal cytokine hemadsorption using the oXiris® membrane—a high-permeability polyacrylonitrile-based (AN69-ST) filter with adsorptive properties against inflammatory mediators—has emerged as a potential adjunct to restore haemodynamic stability. Evidence supporting its use remains limited, particularly regarding timing of initiation and downstream mortality biomarkers. Methods: We conducted a single-centre prospective observational study at the ICU of Istanbul Prof. Dr. Cemil Taşcıoğlu City Hospital between October 2022 and January 2023. Adults aged ≥18 years with VS (CRP ≥ 100 mg/L, procalcitonin [PCT] < 2 μg/L, no positive microbiological culture) requiring continuous renal replacement therapy (CRRT) with the oXiris® membrane were enrolled (n = 34), of whom 30 completed the study period without microbiological exclusion and comprised the final analysis cohort. Pre- and post-treatment (72 h) clinical and cytokine parameters were compared. The association of VS resolution and 7-day mortality with timing of oXiris® initiation, cytokine levels, and treatment duration was assessed. This study was conducted and reported in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement. Results: Significant changes were observed across all principal haemodynamic and inflammatory parameters at 72 h of oXiris® treatment, including mean arterial pressure (MAP: 50.8 ± 6.3 to 69.3 ± 17 mmHg, p < 0.001), SOFA score (8.33 ± 2.29 to 4.9 ± 3.22, p < 0.001), IL-6 (767.3 ± 1205.7 to 294.4 ± 686.3 pg/mL, p < 0.001), IL-1β, TNF-α, CRP, lactate, and creatinine. VS resolved in 24/30 patients (80%). Younger age was associated with VS resolution (57.8 ± 19.7 vs. 76.6 ± 13.9 years; p = 0.021). Initiation of oXiris® within 8 h was associated with significantly shorter VS resolution time (52.5 ± 23.9 vs. 85.9 ± 48.2 h; p = 0.045). Seven-day mortality was 20% (n = 6) and hospital mortality was 50% (n = 15). Post-treatment IL-1β (856.7 ± 548.5 vs. 1086.9 ± 353.6 pg/mL; p = 0.044) and TNF-α (111.0 ± 70.0 vs. 145.4 ± 47.8 pg/mL; p = 0.011) at 72 h were significantly higher in hospital non-survivors, representing exploratory prognostic associations. Conclusions: Changes in haemodynamic and inflammatory parameters were observed during oXiris®-based CRRT treatment in critically ill patients with non-septic VS. Early initiation (≤8 h) was associated with shorter VS resolution time in this exploratory, uncontrolled analysis. Residual IL-1β and TNF-α at 72 h were associated with hospital mortality in exploratory analyses and may represent hypothesis-generating prognostic signals requiring prospective validation. Randomised controlled trials are warranted to confirm these findings and define optimal timing strategies.

26 July 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
SMSinan Mutlu
Sinan Mutlu
HKHakan Küçükkepeci
Hakan Küçükkepeci
EÖECE ÖZCAN
ECE ÖZCAN
KKKadriye Serap Karacalar
Kadriye Serap Karacalar
Background/Objectives: In patients without clinically anticipated difficulty, an unexpected difficult airway carries the greatest potential for harm, yet routine bedside tests exclude difficulty poorly, and evidence for point-of-care ultrasonography remains heterogeneous, with difficult mask ventilation rarely studied as a distinct outcome. We evaluated three rapid anterior-neck ultrasonographic parameters—tongue thickness (TT), skin-to-hyoid-bone distance (SHBD), and cricothyroid membrane length (CTML)—for their diagnostic performance and independent association with a difficult airway in adults without anticipated difficulty. Methods: In this prospective, single-center, diagnostic-accuracy study reported per STARD 2015 and STROBE, 713 adults (ASA I–III) underwent neutral-position measurement of TT, SHBD, and CTML by a sonographer blinded to the clinical assessment and airway-management outcomes. A composite difficult airway (difficult mask ventilation, laryngoscopy, or intubation) was assessed independently. Discrimination was evaluated by ROC analysis with DeLong comparisons, multivariable logistic regression, and bootstrap internal validation; p-values used Benjamini–Hochberg correction. Results: A difficult airway occurred in 197/713 patients (27.6%). TT and SHBD were associated with the composite outcome and all components (AUC 0.68–0.73) and remained independent after adjustment for age, sex, BMI, and Mallampati class; CTML discriminated poorly (AUC ≈ 0.55), with only marginal significance after correction. Negative predictive values were high (78–99%) but prevalence-dependent, with modest likelihood ratios. Adding TT and SHBD to clinical variables improved discrimination (AUC 0.69 → 0.78; DeLong p < 0.001). Conclusions: TT and SHBD show a limited but independent diagnostic signal that may complement, not replace, clinical screening; CTML showed no clinically meaningful discrimination in this cohort. Proposed cut-offs are exploratory and require standardized measurement, reproducibility testing, and external validation before clinical adoption.

1 March 2023 in European Archives of Medical Research
Verified
Journal Article
Closed access
ETEsra Akdaş Tekin
Esra Akdaş Tekin
HKHakan Küçükkepeci
Hakan Küçükkepeci
SMSinan Mutlu
Sinan Mutlu
FGFethi Gültop
Fethi Gültop
HSHüseyin Sevgi
Hüseyin Sevgi
NTNamigar Turgut
Namigar Turgut